Provident Financial director exercises 7,000 options

Provident Financial Holdings director Matthew Webb exercised stock options for 7,000 shares of common stock at $12.09 per share on July 30, 2026, increasing his direct holdings to 8,000 shares.

Accepted by SEC EDGAR 07/31/2026 - 11:43 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Provident Financial Holdings director Matthew Webb exercised stock options for 7,000 shares of common stock at $12.09 per share on July 30, 2026, increasing his direct holdings to 8,000 shares. He continues to hold 17,000 stock options from 2023 and 2024 grants under the Provident 2022 Equity Incentive Plan with vesting dates in 2026, 2027 and 2028.

Insider Trade Summary

7,000 shares exercised/converted

Exercise 2 txns

Insider Webb Matthew

Role Director

Type	Security	Shares	Price	Value
Exercise	Option to Purchase Common Stock F2	7,000	$0.00	$0.00
Exercise	Common Stock, PAR Value $0.01 F1	7,000	$12.09	$85K

Holdings After Transaction: Option to Purchase Common Stock — 17,000 contracts (Direct); Common Stock, PAR Value $0.01 — 8,000 shares (Direct)

Holdings Before and After: Option to Purchase Common Stock, 24,000 to 17,000 contracts (Direct); Common Stock, PAR Value $0.01, 1,000 to 8,000 shares (Direct)

Footnotes (2)

1. F1. Reflects the exercise of stock options under the Provident 2022 Equity Incentive Plan granted on December 14, 2023, and vested on December 14, 2025.
2. F2. Includes 7,000 remaining stock options granted on December 14, 2023 under the Provident 2022 Equity Incentive Plan, which vest on December 14, 2027. Also includes the 10,000 stock options granted on May 23, 2024 under the Provident 2022 Equity Incentive Plan, 50% of which vested on May 23, 2026 and 50% of which will vest on May 23, 2028.

Key Figures

Options Exercised: 7,000 shares Exercise Price: $12.09 per share Common Shares After Transaction: 8,000 shares +3 more

6 metrics

Options Exercised 7,000 shares Common stock acquired on July 30, 2026 through stock option exercise

Exercise Price $12.09 per share Exercise or conversion price for 7,000 stock options into common shares

Common Shares After Transaction 8,000 shares Direct Provident Financial common stock holdings following the reported transactions

Remaining Stock Options 17,000 options Unexercised options held after the July 30, 2026 option exercise

2023 Grant Vesting Date December 14, 2027 Remaining 7,000 options from December 14, 2023 grant vest on this date

2024 Grant Vesting Schedule May 23, 2026 and May 23, 2028 10,000 options; 50% vested in 2026 and 50% vest in 2028

Key Terms

Option to Purchase Common Stock, Provident 2022 Equity Incentive Plan, vested

3 terms

Option to Purchase Common Stock financial

"Listed as the security title "Option to Purchase Common Stock" for the derivative transaction"

Provident 2022 Equity Incentive Plan financial

"Reflects the exercise of stock options under the Provident 2022 Equity Incentive Plan granted on December 14, 2023"

vested financial

"50% of which vested on May 23, 2026 and 50% of which will vest on May 23, 2028"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Matthew Webb report for Provident Financial (PROV)?

Matthew Webb exercised stock options for 7,000 shares of Provident Financial common stock at $12.09 per share on July 30, 2026. These shares came from options granted under the Provident 2022 Equity Incentive Plan that vested on December 14, 2025.

How many Provident Financial (PROV) shares does Matthew Webb own after this transaction?

After the option exercise, Matthew Webb directly owns 8,000 shares of Provident Financial common stock. This reflects the newly issued 7,000 shares from the exercised options plus his prior holdings, as reported in the insider transaction details.

What Provident 2022 Equity Incentive Plan options does Matthew Webb still hold at PROV?

Matthew Webb retains 17,000 stock options: 7,000 from a December 14, 2023 grant vesting December 14, 2027, and 10,000 from a May 23, 2024 grant, half of which vested May 23, 2026 and half vest May 23, 2028.

What was the exercise price of Matthew Webb’s Provident Financial (PROV) stock options?

The exercised stock options had an exercise price of $12.09 per share. Webb converted 7,000 options into common stock at this price, increasing his direct ownership and reducing his outstanding options position accordingly.

Were Matthew Webb’s Provident Financial (PROV) transactions under a Rule 10b5-1 trading plan?

The Rule 10b5-1 checkbox was not marked as affirmative for these transactions. That means the reported option exercise and resulting share acquisition were not affirmed as being executed under a pre-arranged Rule 10b5-1 trading plan.

What future vesting dates apply to Matthew Webb’s remaining PROV stock options?

His remaining options include 7,000 from a December 14, 2023 grant that vest on December 14, 2027, and 10,000 from a May 23, 2024 grant, with 50% vesting on May 23, 2028 after half already vested on May 23, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Webb Matthew

(Last) (First) (Middle)

3756 CENTRAL AVENUE

(Street)

RIVERSIDE CALIFORNIA 92506

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROVIDENT FINANCIAL HOLDINGS INC [ PROV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, PAR Value $0.01	07/30/2026		M		7,000(1)	A	$12.09	8,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$12.09	07/30/2026		M			7,000	12/14/2025	12/14/2033	Common Stock	7,000	$0	17,000(2)	D

Explanation of Responses:

1. Reflects the exercise of stock options under the Provident 2022 Equity Incentive Plan granted on December 14, 2023, and vested on December 14, 2025.

2. Includes 7,000 remaining stock options granted on December 14, 2023 under the Provident 2022 Equity Incentive Plan, which vest on December 14, 2027. Also includes the 10,000 stock options granted on May 23, 2024 under the Provident 2022 Equity Incentive Plan, 50% of which vested on May 23, 2026 and 50% of which will vest on May 23, 2028.

	/s/Matthew E. Webb	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)